Explore the depth of resources available to the Connecticut bioscience community.
Tips and tricks from industry leaders regarding company culture, hiring, resource groups, supply chain, clinical trials, communication and much more.
amplifyHerscience aims to promote awareness and support aspiring innovators who want to extend the impact of their scientific research into the real world.
The findings of BioCT’s 2021 survey highlighting key initiatives people in the bioscience workforce view as important.
A set of practical tools for developing programs, procedures, and best practices to build the right mix for your team. Whether you are just getting started on the journey to a more inclusive work environment or looking to enhance what you already have, these resources will guide and support your efforts.
BioCT’s commitment to addressing racism through our members’ employment practices, their development of therapeutics to benefit all patients, and our support of educational and job initiatives that promote inclusive economic opportunity.
BioCT’s Equity, Diversity & Inclusion Pledge and a commitment to explore ways BioCT can promote ED&I within our community and through collaboration with our members.
In March 2021, Informa Connect Life Sciences conducted one of the biggest studies of its kind, asking life sciences professionals around the world how diverse and inclusive you feel your industry truly is. Get access to the full report, findings, and key insights here.
Written by the Chief Diversity Officer at Alexion Pharmaceuticals, Uzair Qadeer, Ten Dials of Diversity dives into the creation of new DE&I best practices to fit for current circumstances and the unique needs of each corporation.
If you are an employer looking to hire or a person searching for employment, this is a great resource for all.
Connecticut Center for Advanced Technology’s mission is to create bold ideas for success through their technology centers, workforce innovation, funding for manufacturing, and energy solutions
Connecticut’s venture capital arm and the leading source of financing and ongoing support for innovative, growing companies. Funding options include the Connecticut Bioscience Innovation Fund (CBIF), Venture Capital, Capital Access for Business (CAB), and Small Business Innovation.
The Growth Company Grants program provides funding for Connecticut early-stage companies that have achieved some success to help them move to the next level, specifically offering support for strategic projects and customer acquisition. Explore the site to learn more regarding the application process, grant funding, and types of projects the grants support.
Explore funding opportunities, guidance throughout the funding process, and advice from industry experts. Apply now for the opportunity to access $1.2 billion in small business funding from the NIH and STTR.
SBIR Accelerate CT is a CTNext initiative designed to enhance the competitiveness of SBIR/STTR proposals among Connecticut’s small technology companies. The program helps participants compete for more than $3.2 billion in non-dilutive federal research and development funding through the nation’s Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs.
Advance CT’s mission is to build Connecticut into one of the country’s best states for innovation and business development. Here you can explore target industries, news, and featured resources.
reSet is an organization founded to drive new business creation, while simultaneously working to build up the Connecticut entrepreneurial community.
Connecticut’s premiere networking hub for tech companies big and small. Explore the exclusive benefits of membership, networking events, award opportunities and much more!
CTNext helps innovation-based startups in Connecticut. CTNext’s resources and services include mentoring, talent acquisition, capital, skill development, networking, and training. CTNext’s internship program, Technology Talent Bridge, stimulates job creation through innovation, helps companies and students bridge the funding gap, and facilitates post-graduate hiring of students by Connecticut companies.
Learn about the ways the Refinery designs, builds, and implements programming, tools, and mentor networks to fuel the growth of innovation and entrepreneurship.
This office provides help with SBA services including funding programs, counseling, federal contracting certifications, and disaster recovery. They can also connect you to partner organizations, lenders, and other community groups that help small businesses succeed.
Learn about the trained and experienced full-time advisors who work with a variety of small businesses in all industries and stages of development by providing no-cost advisory services.
The region’s designated, private, non-profit Economic Development Organization provides a range of services and resources to stimulate and support economic development and diversification within Southeastern Connecticut. Explore the ways seCTer serves the businesses, residents, and municipalities of New London County and the Town of Windham.
The STEP grant is designed to help Connecticut’s small business community thrive in the global marketplace by increasing the value of small business exports, increasing the number of businesses that export and increasing the number of businesses exploring significant new trade opportunities.
Resources available for Connecticut-based small businesses and entrepreneurs, including CT Business Incubator Network, CT Next, Connecticut Business Connection, CT Economic Resource Center, and many others.
A non-profit organization dedicated to providing tools and resources to help women thrive in business. Explore a multitude of resources including business advising, child care grants, eLearning, and more.
From biotech firms to financial services, from advanced manufacturers to insurance giants, from green energy innovators to digital media wizards, businesses are flourishing in Connecticut. Startups and global leaders alike are capitalizing on key factors for success, like educated and skilled workers who enjoy a high quality of life, a prime Northeast location, the nation’s healthiest residents, and access to financial and technical support. Learn more about the benefits of doing business in Connecticut here.
JLL, a leading commercial real estate firm, issued its first ‘Life Sciences Industry Insight’ for Connecticut. The report finds the state’s life sciences industry has been accelerating at an extremely fast pace. NIH funding and VC funding increased 35% and 93%, respectively, since 2017. Additionally, the number of Life Sciences establishments increased 13% during that same period and created over 1,500 jobs.
AdvanceCT’s first sector snapshot including data and information about talent, real estate, access to capital, and industry strengths. Connecticut is the number 3 state for bioscience venture capital investment, number 4 in the nation for bioscience patents, and number 2 for academic bioscience R&D investment.
State provided statistics describing a few of the reasons so many bioscience companies of all sizes are taking maximum advantage of the state’s dynamic intersection of intellectual capital and practical expertise.
Tools and resources for starting and managing a business including: information on licenses and permits, registering new employees, taxes, and customized checklists to guide you through starting a new business in Connecticut.
Connecticut’s Official State Website with access to economic and community resources such as the CT Small Business Resource Center, the Small Business Resource Guide, Arts Funding Opportunities and Opportunity Zones.
An interactive guide to explore the ways Connecticut supports organizations and companies. Individuals can explore Connecticut driven support options based on industry sector, business size, or specific business objectives.
ODP is Connecticut’s lead agency for the development and implementation of policies, strategies and programs that support business growth and innovation. This webpage also highlights the key initiatives of the ODP such as financing for businesses, tax credit & incentives, workforce training support, and site selection assistance.
A review of the types of support the State of Connecticut provides to help fuel small business growth and contacts for The Office of Small Business Affairs.
The Bioscience Academic and Career Pathway (BioPath) is a partnership between the city of New Haven and Southern Connecticut State University (SCSU). BioPath aims to grow interest and participation in bioscience education by providing academic and experiential learning programs that position graduates for the 21st century workforce.
This fund offers ambitious, high-achieving recent graduates the opportunity to work at top, innovative companies in Connecticut, developing their career while working together as a community of Fellows, growing together professionally and personally to create a cohort of talent, camaraderie, and growth in our state.
PITCH supports translational studies at Connecticut’s most highly funded research university. PITCH funds the research required to show that new therapeutics born from laboratories at this institution can treat cancer; bacterial and fungal infections; inflammatory and autoimmune conditions.
The M&T Bank Center for Innovation and Entrepreneurship is a versatile and collaborative incubator for students, staff and faculty across all of Quinnipiac’s academic disciplines to pursue their entrepreneurial ventures. They provide advisory services and workshops in legal, finance, research, marketing, design, business plan development and start-up mentoring for all types of innovative business, social, sustainable and artistic ventures.
Under the umbrella of UConn’s Office of the Vice President for Research, TCS works with innovators, entrepreneurs, investors, and industry partners to transform UConn discoveries into products, companies, and jobs that benefit society and fuel economic development. Through a coordinated approach between tech transfer, licensing, and startup teams, TCS provides service that enables success for faculty, business, Connecticut, and beyond.
Yale Biotech Club is dedicated to supporting the professional discovery, development, and success of aspiring students & postdoctoral fellows in the life sciences.
Entrepreneurs play a crucial role in successful commercialization of new biomedical technologies. The Blavatnik Fellowship in Life Science Entrepreneurship is designed to foster entrepreneurial skills in the life sciences, linking emerging business leaders with breakthrough innovations from across Yale University.
The Yale Center for Biomedical Innovation and Technology (CBIT), we focus on understanding the challenges arising from the evolution of computing power, increasing transparency in health outcomes and costs, and technological advancements, and partnering with academic innovators, students, corporate entities, and health systems to overcome them.
Works with students from diverse backgrounds and disciplines to seek innovative ways to solve real-world problems. Serves students from across Yale’s campus through programs, funding, and mentoring: whether you have a big idea you’re ready to build on or just want to explore the tools of innovation, they can help you get there.
Yale Ventures is an ambitious new initiative to support and expand innovation and entrepreneurship across the university and throughout the greater New Haven region. Supported by new investments from the university, Yale Ventures supports the translation of university research into impactful products, services, and social ventures to accelerate the expansion of the entrepreneurial ecosystem.
AWIS champions the interests of women in science across all disciplines and employment sectors. Working for positive system transformation, AWIS strives to ensure that all women in these fields can achieve their full potential.
Boston based WEST helps women in science, technology, and engineering advance their careers. Our members are committed to developing themselves as leaders through learning, networking, and sharing.
Seeks to accelerate progress by awarding grants for scientific research that can advance entire fields, building and funding transformative technologies in partnership with the scientific community, and fostering interdisciplinary collaborations in science.
With more than 165 hands-on exhibits, a state-of-the-art 3D digital theater, four educational labs, plus daily programs and events, the Connecticut Science Center offers endless exploration for children, teens, and adults. From physics to forensics, geology to astronomy, visitors have the sciences at their fingertips.
The Connecticut STEM Foundation, Inc. is an all-volunteer non-profit organization. Our mission is to foster interest among all Connecticut high school students in science, technology, engineering, and math (STEM) by providing experiences for them to present their original research and interact with like-minded students and professionals.
CT Women’s Hall of Fame’s primary goal is to provide role models to women of all ages, encouraging them to recognize their potential and live their dreams.
Assists early-career scientists from underrepresented communities through mentoring programs and scholarships to promote diversity in the sciences to further equity, international collaboration, and innovative research.
“I Am A Scientist” is a collection of educational resources designed to challenge public misconceptions and inspire the next generation of STEM leaders.
This powerful digital tool makes high-quality science education accessible and gives learners and educators, everywhere, the courage to chart a meaningful path in science—for free.
MakeHaven, Inc. is a not-for-profit, membership-driven organization, gathering place workshop for makers, creators, tinkerers and dreamers. MakeHaven’s Bio Room is a complete working laboratory for entrepreneurs and enthusiasts to access equipment for advanced biotechnology.
The free K-12 STEM education materials on this site are provided by the institutes and centers within the National Institutes of Health (NIH) and NIH grantees, including Science Education Partnership Award (SEPA) recipients.
A foundation in scientific literacy prepares students to be confident and capable lifelong learners who are equipped with the skills needed to access, understand, evaluate and apply information in various contexts. Regardless of their academic standing, all students should have access to a rich and challenging science curriculum that will promote scientific literacy, while inspiring and supporting advanced study and science-related careers.
Offers challenging STEM programs that promote lifelong learning.
ABCT is the first and only competitive-entry, six-month program of personalized entrepreneurial education created for first time founders of bioscience ventures (of any development stage) focused on healthcare innovation in Connecticut.
BioBoss is a podcast about leadership in the biopharma community. Hear directly from the founders and CEOs of today’s most innovative companies. Listen in as Wyant Simboli Principal and branding veteran John Simboli poses the questions “What drives you? How do you create change? Why should people care?” to biopharma leaders and hear insights on this rapidly developing field.
The series, which has grown out of our Raffa Learning Community effort, features interviews with interesting nonprofit and private sector leaders and those who help them Do More.
Powerful stories of biotechnology breakthroughs, the people they help, and the global problems they solve.
This podcast is a podcast by the Connecticut Academy for Science and Engineering (CASE) with the goal of sharing, with the residents of our state, interesting STEMM developments, and increasing visibility for the state’s innovators and entrepreneurs, businesses and industries, academics, our talented workforce, and those doing STEMM-related work in public service.
Podnosis: the pulse of the healthcare industry. Every week, journalists from Fierce Healthcare dive into some of the industry’s biggest trends. We talk to the experts about what’s important now so you can prep for the future. Hear about all things healthcare, from physician practices to hospital chains and insurance giants—and those that mix all three—plus the tech they use, disruptors looking to compete and people moving the sector forward.
Health-related topics from Connecticut’s public academic medical center.
Science Will Win is a podcast that takes listeners under the microscope of some the most promising medical innovations, exploring therapies which have the potential to shape the future of healthcare and offer new hope to patients around the world. Through conversations with a diverse line-up of guests, including scientists and experts, patient advocates and, most importantly, patients themselves, each miniseries will focus on a unique healthcare challenge, diving into the fascinating science, policy challenges and potential to transform patients’ lives for the better.
Signal is the new voice for next generation biotech leaders. Hosted by Nucleate, a student-led organization that represents the largest global community of bio-innovators.
amplifyHERscience Stories will recount the tales of talented innovators and entrepreneurs, the technologies they’re developing, and the complex paths they’ve traveled to achieve their goals and pursue their passions.
Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech and Fierce Pharma recount the latest industry trends and why they matter. We’ll analyze the week’s biggest business news – from mergers and marketing to drug R&D and device development. Available every Friday morning.
The purpose of the Life-Science Sprints campaign is to help bring awareness to the resources and workforce available in Connecticut for life-science companies. We hope that this initiative will grow our current community and position Connecticut as a leader in this field.
A nonproft fighting poverty, disease, and inequity around the world.
Grantmaking strategies which support biomedical scientists at the beginning of their careers and areas of science that are poised for significant advancement but are currently undervalued and underfunded.
ACCRF is particularly focused on the following research topics: MYB, NOTCH, tumor immune microenvironment and appropriate immunotherapies,diagnostic, prognostic and predictive biomarkers, cell lines and cultures
Funding for research to advance the development of cancer cell and gene therapies with current preference given to new approaches to solid tumors.
ASCO grants and awards support clinical and translational cancer research done by gifted physician-scientists at every stage of their careers.
Funding for projects for a one-year period which will allow the establishment of capabilities of new cancer researchers or new cancer approaches by established cancer researchers.
NFCR provides scientists in the labs the funding they need to make game-changing discoveries in cancer treatments, detection, prevention, and ultimately, a cure for all types of cancer.
Four grants that support young tenure-track faculty early in their cancer research careers, “bench to bedside” research, basic or translation research, and projects to advance research processes such as clinical trials identification, outreach, and enrollment.
Support for programs that cover blood cancer research from the earliest phase of discovery science to translational research that goes from “Bench to Bedside” directly benefiting patients. They provide strong support of today’s promising early-career scientists.
In addition to early-career researchers, LRF funds faculty-level researchers in areas of lymphoma research that may be understudied or have key issues in need of further investigation. These programs, which fall under the larger designation of Disease Focus-Area Grants, solicit innovative research in specific subtypes and/or patient populations, and may also target certain types of research, including studies on biological pathways, correlative studies from existing clinical trials, and collaborative multi-institution projects.
Investment in companies and organizations with profound potential to transform how multiple myeloma is treated by focusing on a portfolio of therapies and technologies, with a strong emphasis on those specializing in immuno-oncology.
The ABTA funds projects through four RFA-driven mechanisms: mentored grants for postdoctoral fellows or medical students, high-risk/high-impact research, and multi-investigator and multi-institutional brain tumor collaborative research projects.
AFTD supports scientists at various stages of their careers in order to advance the understanding of FTD biology and basic disease mechanisms, identify novel approaches to diagnosis and treatment, and develop assistive technologies that support persons with FTD in carrying out activities of daily living.
The Chordoma Foundation aims to catalyze high-impact research that is critical for advancing the discovery of better treatments for chordoma. To that end, they offer a number of funding opportunities to both academic and industry investigators intended to support research in areas identified as priorities by their Scientific Advisory Board.
The SAB invites proposals from pioneering scientists and clinical investigators who have made or are positioned to make critical headway in cancer research.
Komen evaluates and invests in science and technology that will accelerate research discoveries to change the standard of breast cancer care and improve the delivery of that care. They’re focused on conquering aggressive and metastatic breast cancers and eliminating breast cancer disparities.
The ALSF Grant Program funds research every step of the way—from early stage innovative research all the way through to lifesaving clinical trials for kids with cancer.
As the leading non-governmental NF research funder in the US, CTF has acted as a ‘seed funder’ by providing funding especially to early-career NF researchers and to early-stage NF research, both of which require additional time and support before becoming eligible to apply for larger governmental or industrial funding.
St. Baldrick’s funding priorities include new discovery research, translational research, clinical trials and infrastructure, and the next generation of pediatric oncologists. Their focus areas for grants are adolescents & young adults, survivorship, and supportive care research.
The GO2 Foundation for Lung Cancer is committed to funding promising young researchers in the field of lung cancer. Learn more about our research grant opportunities.
MRA supports both individual investigator and collaborative team projects focused on translational, innovative research that will impact the prevention, diagnosis, staging, and treatment of melanoma in the near and intermediate future.
Each year, researchers are invited to submit applications for one-year projects to be conducted in or in conjunction with the dermatology departments of medical or academic institutions in the United States. The program is open to dermatology residents, fellows and investigators within 10 years of their first academic appointment.
The largest private funder of ALS research worldwide, and their efforts have led to some of the most promising and significant advances in the field. The ALS Association supports a wide breadth of specific fields of study that are critical to advancing ALS research.
The ADDF provides funding to academic centers and biotechs from around the world that are advancing therapeutic and biomarker development for Alzheimer’s and related dementias.
To qualify for a Michelson Grant, a proposed project must pursue a technology, mechanism, or pathway representing an innovative approach to nonsurgical sterilization of cats and/or dogs.
Support for a wide range of proposals for impactful and innovative research. Funding opportunities are announced on a rolling basis.
As OREF provides important financial support that helps new investigators build a strong foundation for their research careers. OREF also provides grant funding to established clinicians for whom other funding may be limited due to the area of research being pursued or funding shortfalls.
Autism Speaks Science is committed to being a catalyst for research breakthroughs that improve lives today and deliver a spectrum of solutions in the years ahead. This work involves unraveling the biology of autism, including its varied subtypes and dimensions and translating research findings into life-enhancing solutions.
DEF provides bridge funding that allows promising research to continue while seeking funding from larger sources, such as the National Institute of Health. Providing continuity to these special research projects help to speed discovery of new treatments and cures for sight-threatening eye diseases.
The FFB’s Grants and Awards Programs annually support basic, laboratory-based early translational, clinical studies, and pre-clinical research applicable to a broad range of inherited retinal degenerative diseases. The goal is to find the causes, preventions, treatments, and cures for retinitis pigmentosa, macular degeneration, and the entire spectrum of retinal degenerative diseases.
Through the Emerging Research Grants (ERG) program, Hearing Health Foundation (HHF) provides seed money to researchers working on the entire spectrum of hearing research and balance research, including many underfunded areas of otology.
The CF Foundation supports a wide range of innovative research programs to discover and develop new and effective CF therapies.
The ADA has a strong commitment to research, with a specific focus on funding for early career investigators, fostering the next generation of leaders and support for investigator-initiated research, generating discoveries that will bring effective new treatments and paths to a cure.
Currently Hanuman Medical Foundation is providing funding only for research directly related to the Islet Sheet Project. However, they welcome inquiries from researchers engaged in related work. In particular, hearing from scientists who want to explore encapsulation of their cells in the thin sheet.
Across the country and around the world, leading scientists are working to solve the many parts of the type 1 diabetes puzzle to deliver cures and life-improving breakthroughs. JDRF helps fund their work, connects their research and propels advances forward with the aim of getting solutions to market as quickly as possible.
The Crohn’s and Colitis Foundation supports research projects that ranges across the research continuum, including basic, translational, and clinical research. Additionally, they are committed to supporting a robust pipeline of junior investigators interested in a career in IBD.
The Rainin Foundation’s health grantmaking underscores their commitment to investing early in novel approaches, and their belief that collaboration among investigators and across disciplines can have the greatest impact in Inflammatory Bowel Disease (IBD) research.
The Epilepsy Ventures Fund (EVF) advances therapeutics, diagnostics, devices, wearables, and how we use data to improve the quality of life for people with epilepsy now.
AHA funding supports translation into medical advancements, updated guidelines for healthcare providers to most effectively treat patients and improve people’s well-being, and building careers in science and research.
CHDI Foundation is exclusively dedicated to collaboratively developing therapeutics that will substantially improve the lives of individuals with HD. CHDI accepts both academic and preclinical biopharma proposals.
Cure JM offers grant funding for clinicians and researchers who are working to improve juvenile myositis care and research.
SRF funds research aimed at understanding the pathogenesis of scleroderma and promoting the design, development, and pilot-testing of hypothesis-driven, innovative, therapeutic approaches. The SRF welcomes applications from scientists who have not previously worked on scleroderma, as well as those with substantial ongoing scleroderma–focused effort.
CureDuchenne’s portfolio includes wide-ranging projects aimed at finding treatments for Duchenne, including companies pursuing dystrophin-restoring approaches as well as those developing anti-inflammatory and other mechanisms contributing to the disease. They also look for novel technologies and platform approaches aimed at overcoming the limitations of existing therapies.
MDA will fund a two-year grant to enhance understanding and formulate mitigation strategies for transgene-triggered adverse events. To apply for a Research Grant, you must be an independent investigator.
Each year MTF Biologics awards major grants to applicants selected through a peer review process and provides financial assistance to on-going research projects. Scientific grants are awarded to researchers at accredited institutions in support of the advancement of allograft transplantation.
The Michael J. Fox Foundation funds promising research with a goal to significantly improve the lives of people with Parkinson’s. They welcome applications from academia and industry for support to define, measure and treat Parkinson’s.
The CMTA Board will on occasion seek out targeted proposals in specific disease areas. Funding is not solicited via open calls.
The Fanconi Anemia Research Fund (FARF) seeks to fund interdisciplinary and translational research efforts that will lead to rapid discovery and development of therapies or strategies that treat, control, or cure Fanconi anemia (FA).
PRF’s research focus is highly translational. Topics must fall within the following research priorities: projects that are likely to lead to clinical treatment trials within 5 years, development of gene- and cell-based therapies to treat Progeria, assessment of natural history of disease that may be important to developing outcome measures in treatment trials.
AAFA conducts and promotes research for asthma and allergic diseases. Their research goals include enhancing the understanding of asthma and allergic diseases, developing improved treatments to manage these diseases, searching for cures, supporting advanced training, better understanding patient awareness, how behaviors relate to asthma and allergy prevention and treatment, and improving patient involvement in research – from study design to clinical trial.